Tenax Therapeutics (TENX) Assets (2016 - 2017)
Historic Assets for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $11.0 million.
- Tenax Therapeutics' Assets fell 8157.34% to $11.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $11.0 million, marking a year-over-year decrease of 8157.34%. This contributed to the annual value of $23.3 million for FY2016, which is N/A changed from last year.
- Latest data reveals that Tenax Therapeutics reported Assets of $11.0 million as of Q3 2017, which was down 8157.34% from $13.4 million recorded in Q2 2017.
- Tenax Therapeutics' Assets' 5-year high stood at $73.0 million during Q4 2015, with a 5-year trough of $3.0 million in Q1 2013.
- For the 4-year period, Tenax Therapeutics' Assets averaged around $30.0 million, with its median value being $19.2 million (2017).
- Per our database at Business Quant, Tenax Therapeutics' Assets tumbled by 2320.87% in 2013 and then plummeted by 8157.34% in 2017.
- Quarter analysis of 4 years shows Tenax Therapeutics' Assets stood at $3.2 million in 2013, then soared by 2194.73% to $73.0 million in 2015, then tumbled by 68.02% to $23.3 million in 2016, then tumbled by 52.86% to $11.0 million in 2017.
- Its Assets was $11.0 million in Q3 2017, compared to $13.4 million in Q2 2017 and $19.2 million in Q1 2017.